Clinical Trial Update: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma [Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 2 study evaluating additional chemotherapy after surgery for malignant peritoneal mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peritoneal Mesothelioma
• Mesothelioma
• Peritoneal Mesothelioma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma | Phase 2 | Status: RECRUITING